Department of General Practice and Primary Health Care, Ghent University, Ghent, Belgium.
BMC Health Serv Res. 2010 Jul 14;10:207. doi: 10.1186/1472-6963-10-207.
During a four-year action research project (2003-2007), a program targeting all type 2 diabetes patients was implemented in a well-defined geographical region in Belgium. The implementation of the program resulted in an increase of the overall Assessment of Chronic Illness Care (ACIC) score from 1.45 in 2003 to 5.5 in 2007. The aim of the follow-up study in 2008 was to assess the effect of the implementation of Chronic Care Model (CCM) elements on the quality of diabetes care in a country where the efforts to adapt primary care to a more chronic care oriented system are still at a starting point.
A quasi-experimental study design involving a control region with comparable geographical and socio-economic characteristics and health care facilities was used to evaluate the effect of the intervention in the region. In collaboration with the InterMutualistic Agency (IMA) and the laboratories from both regions a research database was set up. Study cohorts in both regions were defined by using administrative data from the Sickness Funds and selected from the research database. A set of nine quality indicators was defined based on current scientific evidence. Data were analysed by an institution experienced in longitudinal data analysis.
In total 4,174 type 2 diabetes patients were selected from the research database; 2,425 patients (52.9% women) with a mean age of 67.5 from the intervention region and 1,749 patients (55.7% women) with a mean age of 67.4 from the control region. At the end of the intervention period, improvements were observed in five of the nine defined quality indicators in the intervention region, three of which (HbA1c assessment, statin therapy, cholesterol target) improved significantly more than in the control region. Mean HbA1c improved significantly in the intervention region (7.55 to 7.06%), but this evolution did not differ significantly (p = 0.4207) from the one in the control region (7.44 to 6.90%). The improvement in lipid control was significantly higher (p = 0.0021) in the intervention region (total cholesterol 199.07 to 173 mg/dl) than in the control region (199.44 to 180.60 mg/dl). The systematic assessment of long-term diabetes complications remained insufficient. In 2006 only 26% of the patients had their urine tested for micro-albuminuria and only 36% had consulted an ophthalmologist.
Although the overall ACIC score increased from 1.45 to 5.5, the improvement in the quality of diabetes care was moderate. Further improvements are needed in the CCM components delivery system design and clinical information systems. The regional networks, as they are financed now by the National Institute for Health and Disability Insurance (NIHDI), are an opportunity to explore how this can be achieved in consultation with the GPs. But it is clear that, simultaneously, action is needed on the health system level to realize the installation of an accurate quality monitoring system and the necessary preconditions for chronic care delivery in primary care (patient registration, staff support, IT support).
ClinicalTrials.gov Identifier: NCT00824499.
在一个为期四年的行动研究项目(2003-2007 年)中,在比利时一个明确界定的地理区域实施了一个针对所有 2 型糖尿病患者的项目。该项目的实施导致整体慢性病护理评估(ACIC)评分从 2003 年的 1.45 分增加到 2007 年的 5.5 分。2008 年的后续研究旨在评估在一个努力使初级保健更适应慢性病护理导向系统的国家,实施慢性病护理模式(CCM)要素对糖尿病护理质量的影响。
使用具有可比地理和社会经济特征和医疗设施的对照区域的准实验研究设计来评估该区域干预的效果。与相互合作机构(IMA)和两个区域的实验室一起建立了一个研究数据库。使用来自疾病基金的行政数据从研究数据库中定义了两个区域的研究队列。基于当前科学证据,定义了一组九个质量指标。由具有纵向数据分析经验的机构进行数据分析。
从研究数据库中总共选择了 4174 名 2 型糖尿病患者;干预区域 2425 名(52.9%女性)患者,平均年龄为 67.5 岁,对照区域 1749 名(55.7%女性)患者,平均年龄为 67.4 岁。在干预结束时,干预区域的九个定义质量指标中的五个有所改善,其中三个指标(HbA1c 评估、他汀类药物治疗、胆固醇目标)的改善明显高于对照区域。干预区域的平均 HbA1c 显著改善(从 7.55 降至 7.06%),但这一变化与对照区域(从 7.44 降至 6.90%)相比无显著差异(p=0.4207)。在干预区域,血脂控制的改善明显更高(p=0.0021)(总胆固醇从 199.07 降至 173mg/dl),而在对照区域(从 199.44 降至 180.60mg/dl)。对长期糖尿病并发症的系统评估仍然不足。2006 年,只有 26%的患者接受了尿液微量白蛋白检测,只有 36%的患者咨询了眼科医生。
尽管整体 ACIC 评分从 1.45 增加到 5.5,但糖尿病护理质量的改善是适度的。在 CCM 组件交付系统设计和临床信息系统方面需要进一步改进。区域网络,因为它们现在由国家健康和残疾保险研究所(NIHDI)资助,是一个机会,可以在与全科医生协商的情况下探讨如何实现这一目标。但显然,同时,需要在卫生系统层面采取行动,以实现准确的质量监测系统的安装和初级保健中慢性病护理提供的必要前提条件(患者登记、人员支持、IT 支持)。
ClinicalTrials.gov 标识符:NCT00824499。